Patient Safety & Risk Institute Inc is categorized under Insurance Companies in Seneca, SC and active since 2007.
Patient Safety & Risk Institute Inc was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Insurance Companies business, which does work in the BOTH market, and is classified as a Insurance Companies, under code number 524210 by the NAICS.
If you are seeking more information, feel free to contact Corrine Holdridge at the company’s single location by writing to 160 Clydesdale Road, Seneca, South Carolina SC 29678 or by phoning (864) 903-9476. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Patient Safety & Risk Institute Inc |
| Contact Person: | Corrine Holdridge |
| Address: | 160 Clydesdale Road, Seneca, South Carolina 29678 |
| Phone Number: | (864) 903-9476 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | Insurance Companies |
| SIC Code: | 6411 |
| NAICS Code: | 524210 |
| Share This Business: |
Patient Safety & Risk Institute Inc was started in 2007 to provide professional Insurance Companies under the SIC code 6411 and NAICS code 524210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Corrine Holdridge for inquiries that concern Patient Safety & Risk Institute Inc by calling the company number (864) 903-9476, as your correspondence is most welcome. Additionally, the physical location of the single location of Patient Safety & Risk Institute Inc can be found at the coordinates as well as the street address 160 Clydesdale Road in Seneca, South Carolina 29678.
For its online presence, you may visit Patient Safety & Risk Institute Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.